BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1621085)

  • 1. Malignant hyperthermia.
    Larach MG
    Science; 1992 Jul; 257(5066):11-2. PubMed ID: 1621085
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of malignant hyperthermia susceptibility in Denmark.
    Ording H
    Dan Med Bull; 1996 Apr; 43(2):111-25. PubMed ID: 8741205
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA analysis and malignant hyperthermia susceptibility.
    Stowell KM; Pollock N
    Anaesth Intensive Care; 2008 May; 36(3):305-7. PubMed ID: 18564791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hyperthermia: difficulty in diagnosing susceptibility in Spain].
    Montes A; Ramos R; Trillo L; Silva T; Puig MM
    Rev Esp Anestesiol Reanim; 1999 Mar; 46(3):130-2. PubMed ID: 10228380
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant hyperthermia in China.
    Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
    Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant hyperthermia: case-finding of subjects at risk].
    Viering WA; Sengers RC; Stadhouders AM; Gielen MJ; Festen C
    Ned Tijdschr Geneeskd; 1986 May; 130(22):1002-4. PubMed ID: 3724881
    [No Abstract]   [Full Text] [Related]  

  • 7. [Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases. F. Wapplet, et al., AINS 1998;33:373-80].
    Breucking E; Mortier W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):324-7. PubMed ID: 10372223
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-fulminating malignant hyperthermia during a thyroidectomy].
    Sola JL; Bosque F; Arias MN; Facorro ME; Gómez MC
    Rev Esp Anestesiol Reanim; 1994; 41(3):193. PubMed ID: 8059055
    [No Abstract]   [Full Text] [Related]  

  • 9. Current diagnostic methods of malignant hyperthermia: an evaluation.
    Ording H
    Acta Anaesthesiol Belg; 1990; 41(2):103-6. PubMed ID: 2371801
    [No Abstract]   [Full Text] [Related]  

  • 10. Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility.
    Guis S; Bendahan D; Kozak-Ribbens G; Figarella-Branger D; Mattei JP; Pellissier JF; Treffouret S; Bernard V; Lando A; Cozzone PJ
    Arthritis Rheum; 2003 Apr; 49(2):237-8. PubMed ID: 12687516
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurological aspects of malignant hyperthermia. Clinics, physiopathology, genetics].
    Serratrice G; Kozak-Ribbens G; Cozzone PJ
    Rev Neurol (Paris); 1997 Jun; 153(5):304-13. PubMed ID: 9296164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant hyperthermia: 2 years of clinical experience at the center for the study of malignant hyperthermia of Naples].
    Gifuni D; Costantino M; Chiacchio D; Ruggiero A; Cozzolino S; Mancini A; Bellezza G; Ambrosio A; Togo F
    Minerva Anestesiol; 1991 Sep; 57(9):788-9. PubMed ID: 1798581
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant hyperthermia].
    Steinfath M; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Mar; 35(3):147-72. PubMed ID: 10768052
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant hyperthermia.
    Glisson SN
    Compr Ther; 1988 Oct; 14(10):33-41. PubMed ID: 3053015
    [No Abstract]   [Full Text] [Related]  

  • 15. General anesthesia with dexmedetomidine in a malignant hyperthermia-susceptible woman.
    Unger RJ
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1312-3. PubMed ID: 17067340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis of susceptibility to malignant hyperthermia in children].
    Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
    Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia.
    Willner J
    Pediatr Ann; 1984 Feb; 13(2):128, 130, 132-4. PubMed ID: 6369232
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
    Larach MG
    Anesth Analg; 1989 Oct; 69(4):511-5. PubMed ID: 2675676
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant hyperthermia.
    Sessler DI
    Acta Anaesthesiol Scand Suppl; 1996; 109():25-30. PubMed ID: 8901933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Malignant hyperthermia].
    Chastonay P; Bracco D; Freymond D; Ravussin P
    Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.